CDSCO tightens sampling rules: 10 monthly samples per inspector, rural surveillance push
India's drug regulator revised sampling guidelines for drugs, cosmetics and medical devices, mandating minimum 10 samples per inspector monthly (9 drug + 1 cosmetic/device) and expanding surveillance into rural and tribal areas. Pharmacy chains, cosmetics brands and medical device retailers face stricter spurious-product monitoring nationwide.
What happened
CDSCO issued revised sampling guidelines for drugs, cosmetics and medical devices, mandating wider surveillance in rural and tribal areas, stricter monitoring
Key facts
- 10 samples/month
- 9 drug + 1 cosmetic/device
Why this matters
Diligence targets in pharma retail, cosmetics and med-device distribution must now include sampling-failure history and rural compliance readiness as material valuation inputs.